GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer
Conditions: Adult Interventions: Biological: GT201 injection in combination with teraplizumab injection Sponsors: Grit Biotechnology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma Interventions: Biological: GC012F Sponsors: Gracell Biotechnologies Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Phase I Clinical Trial of BH002 in Patients With Advanced Solid Tumors
Conditions: Solid Tumours Interventions: Drug: BH002 Sponsors: Zhuhai Beihai Biotech Co., Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.
Conditions: Relapsed or Refractory Multiple Myeloma Interventions: Drug: MBS314 Injection Sponsors: Beijing Mabworks Biotech Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
First Patient Enrolled in Rise Therapeutics' Rheumatoid Arthritis Clinical Trial
ROCKVILLE, Md., Jan. 29, 2024. Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, today announced that it has enrolled its first patient in its R-2487 Phase 1 rheumatoid arthritis clinical... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 29, 2024 Category: Pharmaceuticals Source Type: clinical trials
An Open-Label Phase I Study to Evaluate the Safety,Tolerability and Preliminary Efficacy of YY001 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumor Interventions: Drug: YY001 Sponsors: Shanghai Yuyao Biotech Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Conditions: Lung Cancer, Non-small Cell; Lung Cancer Metastatic; Solid Tumor, Adult; Advanced Cancer; Lung Cancer, Small Cell; Metastatic Colorectal Cancer; Metastatic Renal Cell Carcinoma; Metastatic Hepatocellular Carcinoma; Metastatic Sarcoma; Metastatic Osteosarcoma Interventions: Biological: KB707 Sponsors: Krystal Biotech, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
An Phase I Study of YY001 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumor Interventions: Drug: YY001 Sponsors: Shanghai Yuyao Biotech Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery
MINNEAPOLIS, Minn., January 28, 2024 – Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced new data presented today at the 60th Annual Meeting of The Society of Thoracic... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 28, 2024 Category: Pharmaceuticals Source Type: clinical trials
An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies
Conditions: Advanced Solid Tumor; Hematological Malignancy Interventions: Drug: YY201 Sponsors: Shanghai Yuyao Biotech Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants
Conditions: Dementia, Frontotemporal Interventions: Drug: VES001; Drug: Placebo Sponsors: Vesper Biotechnologies ApS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus; CAR-T Cell Therapy Interventions: Biological: anti-CD19-CAR-T cells Sponsors: The Children ' s Hospital of Zhejiang University School of Medicine; Chongqing Precision Biotech Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Evaluation of Effects of Dibifree ® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes
Conditions: Type II Diabetes Interventions: Dietary Supplement: Compound plant extracts; Dietary Supplement: Indigestible dextrin Sponsors: Global Preventive Medicine Biotech Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Clinical Evaluation of the Magnesium Absorption Kinetics in Human Plasma Upon Oral Intake of Magnesium-based Products
Conditions: Healthy Volunteers Interventions: Dietary Supplement: Dietary supplementation with Microencapsulated Magnesium; Dietary Supplement: Dietary supplementation with Magnesium Oxide; Dietary Supplement: Dietary supplementation with Magnesium Citrate; Dietary Supplement: Dietary supplementation with Magnesium Bisglycinate Sponsors: Bionos Biotech S.L. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies
Conditions: Advanced Solid Tumors; Hematological Malignancies Interventions: Drug: DXC006 Sponsors: Hangzhou DAC Biotechnology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
